semaglutide effect on heart Demonstrates Impressive Benefits – Even Before You Lose Weight Why Your Cardiologist May Prescribe

Quick refresher: Wegovy is approved by the Food and Drug Administration for chronic weight management in adults with either obesity (body mass index, or BMI, of 30+) or overweight (BMI of 27+) with at least one weight-related medical condition, such as type 2 diabetes, high blood pressure, or high cholesterol

Lifestyle intervention Maintaining a healthy lifestyle is crucial for diabetic patients, including smoking cessation, alcohol moderation, balanced diet, regular exercise, consistent sleep patterns, avoiding prolonged sitting, and reducing mental stress

Use a standard U-100 insulin syringe

Nausea management strategies Nausea is the most common complaint during any GLP-1 medication transition